chr16-57566681-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001304376.3(ADGRG5):c.629G>A(p.Arg210His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,440,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001304376.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRG5 | NM_001304376.3 | c.629G>A | p.Arg210His | missense_variant | 7/12 | ENST00000349457.8 | NP_001291305.1 | |
LOC105371291 | XR_933627.4 | n.1755C>T | non_coding_transcript_exon_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRG5 | ENST00000349457.8 | c.629G>A | p.Arg210His | missense_variant | 7/12 | 1 | NM_001304376.3 | ENSP00000290823 | P1 | |
ADGRG5 | ENST00000340339.4 | c.629G>A | p.Arg210His | missense_variant | 7/12 | 1 | ENSP00000342981 | P1 | ||
ADGRG5 | ENST00000394361.8 | n.715G>A | non_coding_transcript_exon_variant | 7/11 | 2 | |||||
ADGRG5 | ENST00000564607.1 | n.2162G>A | non_coding_transcript_exon_variant | 6/11 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000216 AC: 5AN: 231884Hom.: 0 AF XY: 0.0000318 AC XY: 4AN XY: 125606
GnomAD4 exome AF: 0.0000118 AC: 17AN: 1440238Hom.: 0 Cov.: 30 AF XY: 0.0000140 AC XY: 10AN XY: 715846
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at